Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PacifiCare clarifies Varivax coverage guideline; Merck vaccine added to schedule after consumer complaint.

Executive Summary

PACIFICARE ADDS VARIVAX TO IMMUNIZATION SCHEDULE, CLARIFIES GUIDELINE on use of the Merck chicken pox vaccine, PacifiCare of California announced April 9. "If a plan physician, after discussion with the member-patient, elects to administer the vaccine, the vaccine is a covered benefit," the HMO explained. "If the decision is not to administer the vaccination, PacifiCare will support that decision as well." The HMO described its new guideline as "an effort to clarify some of the ambiguity in our earlier guideline."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel